Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery.
about
Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingSilver nanoparticle protein corona and toxicity: a mini-reviewProbing the Interaction between Nanoparticles and Lipid Membranes by Quartz Crystal Microbalance with Dissipation Monitoring.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Charged group surface accessibility determines micelleplexes formation and cellular interaction.Preparation of Core-Shell Hybrid Materials by Producing a Protein Corona Around Magnetic Nanoparticles.Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics.Differential Impact of Plasma Proteins on the Adhesion Efficiency of Vascular-Targeted Carriers (VTCs) in Blood of Common Laboratory AnimalsEffect of the surface modification, size, and shape on cellular uptake of nanoparticles.A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials.Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivoIn vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells.Synthesis, characterization and radiolabeling of polymeric nano-micelles as a platform for tumor deliveringProtein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity.Nanoparticles as drug carriers: current issues with in vitro testing.Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow.The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome.An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow.Engineering nanoparticles to overcome barriers to immunotherapy.Nanomedicine: Principles, Properties, and Regulatory IssuesIron Oxide Based Nanoparticles for Magnetic Hyperthermia Strategies in Biological ApplicationsExploitation of nanoparticle–protein corona for emerging therapeutic and diagnostic applications
P2860
Q26785347-C308F928-B18A-4A63-AA31-E67FEA014164Q26785864-44DC5131-BBB4-420B-878A-EA73EBDE5DC8Q28071780-F5C680C2-3F9D-4BB4-AC34-0718BD415B87Q33902253-EE4B2E4B-7DB1-4A57-96A7-D4A91D40DA3EQ35776325-1AA42CA3-6154-4139-8E4B-64FEECA50715Q35829035-3D4814AD-7513-496D-8029-7DE7E4EDA80CQ36307546-6B3021B9-8802-4821-82FF-23C7E5EF6F6FQ36900233-4503AA5D-5DD8-4500-ACB7-B26BB1532C5AQ38384069-1B7D287B-5B37-437B-8D6F-C55A1F38A17DQ38665194-ADEAD662-3D7D-40A0-B076-499791FF2E6AQ38949920-B9D10C13-B686-451A-90FD-AFD8FDF46483Q39245827-5CBACF8D-B7C5-4F04-BD83-5837EA7A374DQ41348178-5567834D-F484-4D5F-B3F4-0CEABB8F70A8Q41361113-E2FCD565-8186-4B66-B639-B6D1ADC73DF5Q46454818-105AA139-9965-446B-A803-B5E66F8D68D1Q47644968-7907DA72-8C25-4938-AD36-CA4B7B60FCAEQ49641882-A2014049-12FB-4DE2-9928-BD44012E0641Q51098684-25ABE96C-5B79-4132-873D-4CC296A04CF1Q51135514-67EB9500-6C40-48CD-A1CC-70F45067A23DQ51810666-BB6862B4-7FE4-4B16-89C2-3D7C1CFC54BDQ54991276-210C85E6-974C-4617-BE83-1FE07F6E95C1Q57168448-B6974683-E70C-4BDE-864B-1BA5C63D6697Q57342599-748E2695-734A-4FBC-94C8-0C7D8B9617DBQ57966772-4BA4A479-BAC8-4BAB-B698-2306C93F02B6
P2860
Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biomolecular corona on nanopar ...... ons in targeted drug delivery.
@ast
Biomolecular corona on nanopar ...... ons in targeted drug delivery.
@en
type
label
Biomolecular corona on nanopar ...... ons in targeted drug delivery.
@ast
Biomolecular corona on nanopar ...... ons in targeted drug delivery.
@en
prefLabel
Biomolecular corona on nanopar ...... ons in targeted drug delivery.
@ast
Biomolecular corona on nanopar ...... ons in targeted drug delivery.
@en
P2860
P356
P1476
Biomolecular corona on nanopar ...... ions in targeted drug delivery
@en
P2093
Seungpyo Hong
Vanessa V Juettner
P2860
P356
10.3389/FCHEM.2014.00108
P577
2014-11-27T00:00:00Z